1
|
Jansen JJ, Scheurink J, Balvers T, Fronczek R, Mulleners WM. Beyond coincidence: a case series on the clinical course of coinciding cluster headache and short-lasting unilateral neuralgiform headache attacks. Pain Rep 2025; 10:e1271. [PMID: 40303899 PMCID: PMC12040040 DOI: 10.1097/pr9.0000000000001271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2024] [Revised: 02/11/2025] [Accepted: 02/17/2025] [Indexed: 05/02/2025] Open
Abstract
Introduction Limited research has been conducted on co-occurring cluster headache and short-lasting unilateral neuralgiform headache attacks (SUNHA). Objectives This case series aims to explore whether the observed overlap of cluster headache and SUNHA reflects a coincidental co-occurrence or suggests a shared underlying mechanism while also providing insights to improve diagnosis and management of these patients. Methods A retrospective case series of 10 patients with a diagnosis of both cluster headache and SUNHA. Results Two patients exhibited simultaneous onset of cluster headache and SUNHA (concurrent cluster-SUNHA), whereas the remaining 8 had consecutive cluster-SUNHA. Overlapping localization of pain and autonomic symptoms were observed in 9 of 10 cases. Magnetic resonance imaging was performed in 8 patients, revealing an ipsilateral trigeminal neurovascular conflict in half of them. Four patients underwent microvascular decompression, which exhibited varying efficacy on both cluster headache and SUNHA. Conclusion This study constitutes the most extensive description to date of individuals diagnosed with both cluster headache and SUNHA. The observed co-occurrence of these headache types could suggest a pathophysiological relationship between the 2, which might be explained by a bidirectional interaction between posterior hypothalamic function and trigeminal root demyelination. The role of a trigeminal neurovascular conflict seems likely in this context, with dedicated magnetic resonance imaging being the optimal method for its identification. The potential role of microvascular decompression as a treatment in cluster-SUNHA cases where such a conflict is identified warrants further investigation.
Collapse
Affiliation(s)
- Julia J. Jansen
- Department of Neurology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, the Netherlands
- Radboud University Medical Center, Nijmegen, the Netherlands
| | - Job Scheurink
- Radboud University Medical Center, Nijmegen, the Netherlands
| | - Tijmen Balvers
- Department of Epilepsy, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands
| | - Rolf Fronczek
- Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands
- Stichting Epilepsie Instellingen Nederland (SEIN), Sleep-Wake Centre, Heemstede, the Netherlands
| | | |
Collapse
|
2
|
Lansbergen CS, Fronczek R, Wilbrink LA, Cohen SP, de Vos CC, Huygen FJPM. 15. Cluster Headache. Pain Pract 2025; 25:e70050. [PMID: 40437707 PMCID: PMC12120220 DOI: 10.1111/papr.70050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2024] [Revised: 03/11/2025] [Accepted: 05/05/2025] [Indexed: 06/01/2025]
Abstract
INTRODUCTION Cluster headache is a rare primary headache disorder characterized by excruciating unilateral pain around the eye, lasting between 15 and 180 min, accompanied by ipsilateral cranial autonomic symptoms. Cluster headache is classified into two forms: episodic and chronic, with chronic cluster headache defined by pain-free intervals of less than 3 months between bouts. Both drug-based and invasive treatments are available for abortive and preventive purposes. Treatment selection depends on individual efficacy and tolerance, with invasive options considered when pharmacological treatments prove ineffective. METHODS This narrative review summarizes the literature on common practice and the evidence in the treatment of cluster headache. RESULTS Oxygen therapy and subcutaneous sumatriptan are the most effective abortive treatments for cluster headache. Oral corticosteroid tapering regimens can be used as bridging therapy. Verapamil, lithium, topiramate, and CGRP antagonists are potential preventive medication options. Greater occipital nerve (GON) injections and radiofrequency (RF) therapy can be used as preventive treatments, though their effects are often temporary. For refractory chronic cluster headache, occipital nerve stimulation (ONS) has proven to be effective. Deep brain stimulation (DBS) may also be considered if all other treatments have failed. CONCLUSIONS The management of cluster headache is complex due to the variable efficacy of treatments across different patients and limited evidence.
Collapse
Affiliation(s)
- Casper S. Lansbergen
- Department of Anesthesiology, Center for Pain MedicineErasmus MC University Medical CenterRotterdamthe Netherlands
| | - Rolf Fronczek
- Department of NeurologyLeiden University Medical CenterLeidenthe Netherlands
| | | | - Steven P. Cohen
- Department of Anesthesiology, Neurology, Physical Medicine & Rehabilitation, Psychiatry and Neurological SurgeryNorthwestern University Feinberg School of MedicineChicagoIllinoisUSA
- Department of Anesthesiology and Physical Medicine & Rehabilitation, Walter Reed National Military Medical CenterUniformed Services University of the Health SciencesBethesdaMarylandUSA
| | - Cecile C. de Vos
- Department of Anesthesiology, Center for Pain MedicineErasmus MC University Medical CenterRotterdamthe Netherlands
| | - Frank J. P. M. Huygen
- Department of Anesthesiology, Center for Pain MedicineErasmus MC University Medical CenterRotterdamthe Netherlands
| |
Collapse
|
3
|
Cho S, Lee MJ, Chu MK, Park JW, Moon HS, Chung PW, Sohn JH, Kim BS, Kim D, Oh K, Kim BK, Cho SJ. Pain Lateralization in Cluster Headache and Associated Clinical Factors. J Clin Neurol 2025; 21:220-229. [PMID: 40308017 PMCID: PMC12056138 DOI: 10.3988/jcn.2024.0457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2024] [Revised: 02/21/2025] [Accepted: 03/04/2025] [Indexed: 05/02/2025] Open
Abstract
BACKGROUND AND PURPOSE The pain lateralization in cluster headache (CH) may be related to the asymmetry in the functions of the brain hemispheres. The right-sided dominance of pain in CH has been found inconsistently across studies, and so we aimed to characterize this and identify the factors influencing pain lateralization during current and previous bouts. METHODS This study enrolled 227 patients from the Korean Cluster Headache Registry between October 2018 and December 2020. We evaluated the side of pain during current and previous bouts, demographic features, and clinical characteristics, including handedness. Multivariable logistic regression analyses were performed to identify factors associated with the side of pain. RESULTS The 227 patients with CH included 131 (57.7%) with right-sided pain and 86 (37.9%) with left-sided pain during the current bout (p<0.001). The 189 patients with previous bouts of CH included 86.8% who consistently reported the same side of pain throughout multiple bouts (side-locked pain), with a higher prevalence of pain on the right than the left side (55.0% vs. 31.7%, p<0.001). Multivariable analyses revealed that higher age at diagnosis (odds ratio [OR]=1.045, p=0.031) and shorter CH attacks (OR=0.992, p=0.017) were associated with left-side-locked pain. However, handedness was not associated with the lateralization of left-side-locked pain. CONCLUSIONS This study has confirmed the predominance of right-sided pain throughout multiple CH bouts. We found that higher age at diagnosis and shorter CH attacks were associated with left-side-locked pain, suggesting that certain clinical factors are associated with the pain laterality. However, the underlying mechanisms linking these factors to lateralized pain remain unclear and therefore require further investigation.
Collapse
Affiliation(s)
- Soohyun Cho
- Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea
| | - Mi Ji Lee
- Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
| | - Min Kyung Chu
- Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Jeong Wook Park
- Department of Neurology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea
| | - Heui-Soo Moon
- Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Pil-Wook Chung
- Department of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Jong-Hee Sohn
- Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea
| | - Byung-Su Kim
- Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea
| | - Daeyoung Kim
- Department of Neurology, Chungnam National University College of Medicine, Daejeon, Korea
| | - Kyungmi Oh
- Department of Neurology, Korea University College of Medicine, Seoul, Korea
| | - Byung-Kun Kim
- Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
| | - Soo-Jin Cho
- Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.
| |
Collapse
|
4
|
Redon S, Hirtz C, Quesnel L, Donnet A. A case of de novo bilateral chronic cluster headache responding to calcitonin gene-related peptide antibodies. Rev Neurol (Paris) 2024; 180:698-699. [PMID: 38429157 DOI: 10.1016/j.neurol.2023.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 11/30/2023] [Accepted: 12/06/2023] [Indexed: 03/03/2024]
Affiliation(s)
- S Redon
- Department of Evaluation and Treatment of Pain, FHU INOVPAIN, CHU Timone, AP-HM, Marseille, France.
| | - C Hirtz
- Department of Evaluation and Treatment of Pain, FHU INOVPAIN, CHU Timone, AP-HM, Marseille, France
| | - L Quesnel
- Neurology, HIA Sainte-Anne, Toulon, France
| | - A Donnet
- Department of Evaluation and Treatment of Pain, FHU INOVPAIN, CHU Timone, AP-HM, Marseille, France; CHU de Clermont-Ferrand, Inserm U-1107, Clermont-Ferrand, France
| |
Collapse
|
5
|
Søborg MLK, Petersen AS, Lund N, Barloese MCJ, Jensen RH. Transition of cluster headache: Depicting side-changing attacks as a chronic trait in an interview-based follow-up study. Cephalalgia 2024; 44:3331024241258485. [PMID: 38884805 DOI: 10.1177/03331024241258485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/18/2024]
Abstract
BACKGROUND Cluster headache presents in an episodic and chronic form, between which patients can convert during the course of disease. We aimed to quantify the rate of cluster headache patients changing phenotype within one and five years and investigate the earlier proposed association between chronification and having side-shifting attacks. METHODS In total, 430 cluster headache patients well-characterized according to current International Classification of Headache Disorders criteria, who were all participants in a prior transition-study, were re-interviewed in an observational, retrospective, cross-sectional follow-up study design at the Danish Headache Center. RESULTS The transition rate for the whole cohort was 6.5% within one year and 19.8% within five years. The risk of becoming chronic if episodic was 4.0% within one year and 12.3% within five years. For conversion from chronic to episodic, the corresponding risk was 11.1% and 25.0%, respectively. Alterations in attack-side were reported in 32% of all chronic patients, generating an odds ratio of 2.24 of being chronic as opposed to episodic if experiencing side-shifting attacks. CONCLUSIONS A higher transition rate since the original cross-sectional study demonstrates cluster headache as a non-static condition. Identifying a risk of transition within one and five years, based on current phenotype along with high odds of being chronic when experiencing a shift of attack-side, offers a valuable clinical compass in the dialogue with the patient.
Collapse
Affiliation(s)
- Marie-Louise Kulas Søborg
- The Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, University of Copenhagen, Glostrup, Denmark
| | - Anja Sofie Petersen
- The Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, University of Copenhagen, Glostrup, Denmark
| | - Nunu Lund
- The Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, University of Copenhagen, Glostrup, Denmark
| | - Mads Christian Johannes Barloese
- Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark
| | - Rigmor Højland Jensen
- The Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, University of Copenhagen, Glostrup, Denmark
| |
Collapse
|